Skip to main content
Caplight Logo









Oria Bioscience

Oria Bioscience

Private
ParisHealthcare & Life Scienceshttps://oriabs.com/

Last Round

Seed

Jun 19, 2025

Total Funding Raised

$6.7M

Company Overview

Oria Bioscience is a biotechnology company that provides industrial-scale, purified native organelles for high-throughput drug discovery and screening applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

organelle isolationmicrofluidicsdrug discoveryhigh-throughput screeningintracellular assaysbiological reagentslab-on-a-chipCROcontract research organizationbiotech toolsassay developmenthit-to-lead optimizationlife science reagentssubcellular fractionation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oria Bioscience Comparables

Compare Oria Bioscience with similar companies based on industry and business-model similarity.

Oria Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Miphic
72%
Invent Biotechnologies Inc.
71%
Creative BioMart
63%

Oria Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 19, 2025
GrantMar 1, 2024

Key People

Founding team and executive leadership

Marine Moutia

Chief Operating Officer & Co-founder

Founding Team

Alexandre SANTINHO

Chief Executive Officer at Oria Bioscience

Executive Team

Oria Bioscience Investors

Notable investors and investment history

Oria Bioscience investors
InvestorRounds
Région Île-de-FranceGrant
Agence Nationale de la RechercheGrant
Galion.exeSeed
BpifranceGrant
Newfund CapitalSeed
CenitzSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 30, 2026

    Monthly visitors increased 54% MoM.

  • May 13, 2026

    Monthly visitors increased 36% MoM, from 910 to 1.2K.

Oria Bioscience Filings

Explore SEC and related filing metadata, where available.

Oria Bioscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Oria Bioscience's valuation, stock price, and market status.

Is Oria Bioscience a public or private company?

Oria Bioscience is a private company.

What is the current stock price of Oria Bioscience?

Oria Bioscience is a private company with no public stock price. Caplight tracks Oria Bioscience's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Oria Bioscience worth (valuation)?

Valuation information for Oria Bioscience is not publicly available.

Can I buy Oria Bioscience stock?

Oria Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Oria Bioscience's last funding round?

Oria Bioscience's most recent funding round was Seed on June 19, 2025.

Who are the main investors in Oria Bioscience?

Key investors in Oria Bioscience include Galion.exe, Newfund Capital.

Will Oria Bioscience IPO soon?

No public IPO plans have been announced for Oria Bioscience.

How can I track Oria Bioscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oria Bioscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range13
Year Founded2024
Last FundingJun 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?